These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Recent progress in the development of histone deacetylase inhibitors as anti-cancer agents. Zhang L; Lei J; Shan Y; Yang H; Song M; Ma Y Mini Rev Med Chem; 2013 Dec; 13(14):1999-2013. PubMed ID: 24160707 [TBL] [Abstract][Full Text] [Related]
6. The effect of various zinc binding groups on inhibition of histone deacetylases 1-11. Madsen AS; Kristensen HM; Lanz G; Olsen CA ChemMedChem; 2014 Mar; 9(3):614-26. PubMed ID: 24375963 [TBL] [Abstract][Full Text] [Related]
7. Peptide based macrocycles: selective histone deacetylase inhibitors with antiproliferative activity. Rajak H; Singh A; Dewangan PK; Patel V; Jain DK; Tiwari SK; Veerasamy R; Sharma PC Curr Med Chem; 2013; 20(14):1887-903. PubMed ID: 23409715 [TBL] [Abstract][Full Text] [Related]
8. HDAC as onco target: Reviewing the synthetic approaches with SAR study of their inhibitors. Sangwan R; Rajan R; Mandal PK Eur J Med Chem; 2018 Oct; 158():620-706. PubMed ID: 30245394 [TBL] [Abstract][Full Text] [Related]
9. Largazole Analogues as Histone Deacetylase Inhibitors and Anticancer Agents: An Overview of Structure-Activity Relationships. Poli G; Di Fabio R; Ferrante L; Summa V; Botta M ChemMedChem; 2017 Dec; 12(23):1917-1926. PubMed ID: 29117473 [TBL] [Abstract][Full Text] [Related]
10. Novel inhibitors of human histone deacetylases: design, synthesis and bioactivity of 3-alkenoylcoumarines. Seidel C; Schnekenburger M; Zwergel C; Gaascht F; Mai A; Dicato M; Kirsch G; Valente S; Diederich M Bioorg Med Chem Lett; 2014 Aug; 24(16):3797-801. PubMed ID: 25042254 [TBL] [Abstract][Full Text] [Related]
11. Macrocyclic compounds as anti-cancer agents: design and synthesis of multi-acting inhibitors against HDAC, FLT3 and JAK2. Ning CQ; Lu C; Hu L; Bi YJ; Yao L; He YJ; Liu LF; Liu XY; Yu NF Eur J Med Chem; 2015 May; 95():104-15. PubMed ID: 25800646 [TBL] [Abstract][Full Text] [Related]
12. [Synthesis and activity of some new histone deacetylases inhibitors]. Cheng YH; Guo YS; Han HZ; Wang N; Zhang GH; Guo ZR; Wu S Yao Xue Xue Bao; 2010 Jun; 45(6):735-41. PubMed ID: 20939182 [TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of a new generation of substituted purine hydroxamate analogs as histone deacetylase inhibitors. Liu R; Wang J; Tang W; Fang H Bioorg Med Chem; 2016 Apr; 24(7):1446-54. PubMed ID: 26907204 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of bisthiazole-based trifluoromethyl ketone derivatives as potent HDAC inhibitors with improved cellular efficacy. Gong CJ; Gao AH; Zhang YM; Su MB; Chen F; Sheng L; Zhou YB; Li JY; Li J; Nan FJ Eur J Med Chem; 2016 Apr; 112():81-90. PubMed ID: 26890114 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and preliminary bioactivity studies of 1,3,4-thiadiazole hydroxamic acid derivatives as novel histone deacetylase inhibitors. Guan P; Sun F; Hou X; Wang F; Yi F; Xu W; Fang H Bioorg Med Chem; 2012 Jun; 20(12):3865-72. PubMed ID: 22579621 [TBL] [Abstract][Full Text] [Related]
16. Histone Deacetylase 11 Is an ε-N-Myristoyllysine Hydrolase. Moreno-Yruela C; Galleano I; Madsen AS; Olsen CA Cell Chem Biol; 2018 Jul; 25(7):849-856.e8. PubMed ID: 29731425 [TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of novel and highly-active pan-histone deacetylase (pan-HDAC) inhibitors. Tashima T; Murata H; Kodama H Bioorg Med Chem; 2014 Jul; 22(14):3720-31. PubMed ID: 24864038 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological evaluation of 1, 3-disubstituted-pyrazole derivatives as new class I and IIb histone deacetylase inhibitors. Yao Y; Liao C; Li Z; Wang Z; Sun Q; Liu C; Yang Y; Tu Z; Jiang S Eur J Med Chem; 2014 Oct; 86():639-52. PubMed ID: 25218912 [TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of mono and bicyclic tetrapeptides thioester as potent inhibitor of histone deacetylases. Hoque MA; Islam MS; Islam MN; Kato T; Nishino N; Ito A; Yoshida M Amino Acids; 2014 Oct; 46(10):2435-44. PubMed ID: 25048030 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological characterization of spiro[2H-(1,3)-benzoxazine-2,4'-piperidine] based histone deacetylase inhibitors. Thaler F; Varasi M; Abate A; Carenzi G; Colombo A; Bigogno C; Boggio R; Zuffo RD; Rapetti D; Resconi A; Regalia N; Vultaggio S; Dondio G; Gagliardi S; Minucci S; Mercurio C Eur J Med Chem; 2013 Jun; 64():273-84. PubMed ID: 23644210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]